Press Releases
Please view the latest press from Enzo Biochem, Inc.
Date | Details |
Monday December 28, 2020 | ENZO RESPONDS AFTER REVIEWING THE POSITION OF INSTITUTIONAL SHAREHOLDER SERVICES |
Tuesday December 15, 2020 | Enzo Biochem Hosting Key Opinion Leader Call on GENFLEX™ Molecular System for COVID-19 and the Role of Testing in a Post-Vaccine Treatment Environment |
Wednesday December 09, 2020 | Enzo Biochem Reports First Quarter Fiscal 2021 Financial Results and Provides Business Update |
Wednesday December 02, 2020 | Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9 |
Wednesday November 25, 2020 | ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS |
Wednesday November 18, 2020 | ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS |
Tuesday November 17, 2020 | ENZO PROVIDES CORPORATE BUSINESS UPDATE |
Thursday November 05, 2020 | ENZO LAUNCHES PORTABLE MICROPLATE READER FOR USE WITH ITS ELISA AND ASSAY KITS TO SIMPLIFY LABORATORY WORKFLOW |
Tuesday October 27, 2020 | ENZO BIOCHEM LAUNCHES GOTESTMENOW™ ONLINE PLATFORM FOR CONSUMERS TO DIRECTLY ORDER COVID-19 LABORATORY TESTS |
Tuesday October 13, 2020 | Enzo Biochem Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update |
Tuesday October 06, 2020 | Enzo Biochem to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, October 13 |
Tuesday September 08, 2020 | ENZO BIOCHEM DOUBLES CAPACITY IN RESPONSE TO INCREASING DEMAND FOR COVID-19 TESTING |
Tuesday July 21, 2020 | ENZO BIOCHEM TO PROVIDE ACCESS TO COVID-19 TESTING AT MORE THAN 50 NY PHARMACIES IN COLLABORATION WITH CPESN NY |
Monday July 13, 2020 | Enzo Biochem Receives Emergency Use Authorization for Proprietary Test System for Detection of Coronavirus SARS-CoV-2 |
Tuesday June 30, 2020 | Enzo Biochem to Provide COVID-19 Testing to Farmingdale State College Staff and Students as They Return to Campus |
Tuesday June 23, 2020 | Enzo Announces Issuance of U.S. Patent for Methods of Treating Liver Cancer Using Proprietary Compound SK1-I |
Monday June 08, 2020 | ENZO BIOCHEM REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS |
Wednesday June 03, 2020 | Enzo Biochem to Announce Third Quarter 2020 Financial Results on Monday June 8, 2020 |
Wednesday May 20, 2020 | Enzo Biochem Launches Proprietary Test for Detection of Coronavirus SARS-CoV- 2 IgG Antibody Under FDA’s Emergency Use Authorization |
Tuesday May 12, 2020 | Enzo Announces Issuance of U.S. Patent for Methods of Producing Monoclonal Antibodies Against Osteoporosis Drug Target Sclerostin |
Wednesday April 29, 2020 | Enzo Announces Issuance of U.S. Patent for Methods of Using Proprietary Compound SK1-I in Patients; Exploring Options for Development as a Potential Treatment for COVID-19 |
Thursday April 23, 2020 | Enzo Biochem Launches Proprietary COVID-19 Diagnostic Test Under FDA’s Emergency Use Authorization |
Tuesday March 24, 2020 | Enzo Biochem’s Clinical Labs Subsidiary Launches Drive-Through Facility to Provide COVID-19 Testing on Long Island |
Friday March 6, 2020 | Enzo Biochem’s Full Service Clinical Laboratory to Launch Coronavirus (COVID-19) Testing Services Next Week |
Thursday March 5, 2020 | Enzo Biochem Reports Fiscal Second Quarter Results |
Tuesday February 25, 2020 | Enzo Biochem Announces Preliminary Results of Voting at Annual Shareholder Meeting |
Wednesday February 19, 2020 | Enzo Biochem Reports Publication of Study Detailing Promising Activity of Drug Candidate SK1‑I in a Model of Lupus |
For further information, please refer to: Regulatory role of SphK1 in TLR 7/9 – dependent type I interferon response and autoimmunity https://faseb.onlinelibrary.wiley.com/doi/epdf/10.1096/fj.201902847R |
|
Tuesday February 11, 2020 | Enzo Biochem Announces Significant Milestone with Approval of Proprietary GenFlex Platform |
Tuesday January 28, 2020 | Enzo Biochem Proposes to Increase Size of Board and Will Appoint Additional Highly Qualified, Diverse Independent Director in Near Future |
Monday January 13, 2020 | Enzo Biochem Responds to Series of Misleading and Inaccurate Statements from Activist Hedge Fund Harbert |